SPY334.55-0.02 -0.01%
DIA277.02+2.40 0.87%
IXIC10,923.72-87.26 -0.79%

Acer Therapeutics Q3 EPS $(0.52) Down From $(0.43) YoY

Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.52) per share. This is a 20.93 percent decrease over losses of $(0.43) per share from the same period last year.

Benzinga · -

Acer Therapeutics (NASDAQ:ACER) reported quarterly losses of $(0.52) per share. This is a 20.93 percent decrease over losses of $(0.43) per share from the same period last year.